CATABASIS PHARMACEUTICALS IN's ticker is CATB and the CUSIP is 14875P107. A total of 26 filers reported holding CATABASIS PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $65,000 | -39.3% | 18,108 | +4.1% | 0.00% | – |
| Q3 2016 | $107,000 | +67.2% | 17,402 | -0.1% | 0.00% | – |
| Q2 2016 | $64,000 | -88.9% | 17,424 | -84.8% | 0.00% | – |
| Q1 2016 | $578,000 | -39.7% | 114,730 | -5.2% | 0.00% | – |
| Q4 2015 | $959,000 | +10.6% | 120,985 | +12.8% | 0.00% | – |
| Q3 2015 | $867,000 | – | 107,223 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 2,680,752 | $2,571,000 | 3.20% |
| Stonepine Capital Management, LLC | 2,400,000 | $2,302,000 | 1.40% |
| SV Health Investors, LLC | 2,857,667 | $2,740,000 | 1.26% |
| Clarus Ventures, LLC | 2,008,192 | $1,925,000 | 0.68% |
| ARMISTICE CAPITAL, LLC | 2,000,000 | $1,918,000 | 0.12% |
| FEDERATED HERMES, INC. | 10,434,000 | $10,006,000 | 0.03% |
| Alyeska Investment Group, L.P. | 1,121,505 | $1,076,000 | 0.01% |
| Alyeska Investment Group, L.P. | 1,000,000 | $959,000 | 0.01% |
| HRT FINANCIAL LP | 24,000 | $23,000 | 0.01% |
| OPPENHEIMER & CO INC | 198,000 | $190,000 | 0.01% |